What does CUSIP 75886F957 represent in this 13F holders report?

CUSIP 75886F957 is the security identifier for 75886F957 - REGENERON PHARMACEUTICALS - COM - Put used to aggregate holder disclosures.

How many institutions held 75886F957 - REGENERON PHARMACEUTICALS - COM - Put in Q4 2020?

No institutional holders were reported for 75886F957 - REGENERON PHARMACEUTICALS - COM - Put in Q4 2020; review adjacent reporting periods for trend context.

REGENERON PHARMACEUTICALS - COM - Put

CUSIP: 75886F957

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -3,400
Total reported value: $0
Price per share: $483.11
Number of holders: 0
Value change: -$1,903,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 75886F957?
CUSIP 75886F957 identifies 75886F957 - REGENERON PHARMACEUTICALS - COM - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 75886F957:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

REGENERON PHARMACEUTICALS - COM - Put

Q4 2020 13F Holders as of 31 Dec 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of REGENERON PHARMACEUTICALS - COM - Put as of Q4 2020.